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Screening of marine natural products for antitumor activities 
led to the discovery of glycolipids termed agelasphines, from 
wich α-GalCer (1) was obtained by structural optimization. α-
GalCer is presented by CD1d-molecules on antigen 
presenting cells to the TCR of iNKT cells, which upon 
activation rapidly secrete Th1 and Th2 cytokines. Th1 
cytokines mediate protective immune functions like tumor 
rejection, antiviral and antibacterial effects, while Th2 
cytokines mediate regulatory immune functions to ameliorate 
autoimmune diseases. The fact that Th1 and Th2 cytokines 
antagonize each other’s effect is believed to be responsible for 
the limited clinical benefit obtained with α-GalCer.
1
 Hence, 
analogues that are capable of polarising the cytokine response 
to either Th1 or Th2 are of great interest. 
In this poster a divergent synthetic pathway is described to 
afford α-GalCer analogous containing an amide moiety in the 
poorly investigated phytosphingosine chain. 
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